Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF).
Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.
Multiple sclerosis and the blood-central nervous system barrier.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.
What is the relevance of quality of life assessment for patients with attention impairment?
[Cognitive disorders in adolescents with multiple sclerosis: problem and methods].
Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
Sunshine and multiple sclerosis.
Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.
Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
Transient Brain Lesions in Neuro-Behçet's Disease without Systemic Involvement.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »